Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type

Clinical trial NCT00190411 · COMPLETED

Trial details

NCT number: NCT00190411
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT CHROMOSOME 2q31.2 DELETION SYNDROME

Start date: 2003-10-01
Primary completion: 2011-04-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.